nicotinamide phosphoribosyl transferase inhibitor (TopoTarget)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namenicotinamide phosphoribosyl transferase inhibitor (TopoTarget)
Drug Alias NameNAMPT inhibitor (TopoTarget)TP-201565
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinamide phosphoribosyltransferase inhibitors
TargetsNicotinamide phosphoribosyltransferase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTopotarget AS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTopotarget AS
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A